Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study. Bone Marrow Transplant 2024 Jan;59(1):121-124
Date
10/07/2023Pubmed ID
37803198DOI
10.1038/s41409-023-02096-zScopus ID
2-s2.0-85173730029 (requires institutional sign-in at Scopus site) 2 CitationsAuthor List
Mohan M, Kothari A, Verhagen N, Shreenivas A, Radhakrishnan SV, Dhakal B, Figueroa-Castro C, Chhabra S, Janz S, Pasquini M, Hamadani M, Szabo A, D'Souza A, N3C consortiumAuthors
Anita D'Souza MD Professor in the Medicine department at Medical College of WisconsinBinod Dhakal MBBS, MD Professor in the Medicine department at Medical College of Wisconsin
Carlos E. Figueroa Castro MD Associate Professor in the Medicine department at Medical College of Wisconsin
Mehdi Hamadani MBBS Professor in the Medicine department at Medical College of Wisconsin
Siegfried Janz MD Professor in the Medicine department at Medical College of Wisconsin
Anai N. Kothari MD Associate Professor in the Surgery department at Medical College of Wisconsin
Sabarinath Venniyil Radhakrishnan MD Assistant Professor in the Medicine department at Medical College of Wisconsin
Aniko Szabo PhD Professor in the Data Science Institute department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
Bone MarrowHumans
Transplants
